CN102430007A - Weight-losing Chinese patent medicine capable of eliminating fat and treating fatty liver obesity - Google Patents
Weight-losing Chinese patent medicine capable of eliminating fat and treating fatty liver obesity Download PDFInfo
- Publication number
- CN102430007A CN102430007A CN2011104330257A CN201110433025A CN102430007A CN 102430007 A CN102430007 A CN 102430007A CN 2011104330257 A CN2011104330257 A CN 2011104330257A CN 201110433025 A CN201110433025 A CN 201110433025A CN 102430007 A CN102430007 A CN 102430007A
- Authority
- CN
- China
- Prior art keywords
- parts
- fatty liver
- fat
- chinese patent
- patent medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a weight-losing Chinese patent medicine named as No.8 Xiaoling decoction) capable of eliminating fat and treating fatty liver obesity, which comprises Chinese wolfberry, lucid ganoderma, rhubarb, ginseng, giant knotweed rhizome and liquoric root. The weight-losing Chinese patent medicine capable of eliminating fat and treating fatty liver obesity is prepared from pure Chinese medicines, has the advantages of good treatment effect, small side effect, short treatment course and the like, can eliminate fat and treat fatty liver obesity, and has the characteristics of quick response and high cure rate.
Description
[technical field]
The present invention relates to a kind of pharmaceutical formulation, relate in particular to the fat-reducing Chinese patent medicine that to eliminate fat treatment obese fatty liver disease.
[background technology]
In process is cured the disease in present clinical application, generally all be to be main with the single relatively medicine of function, can not satisfy the requirement of the multiple disease of treatment.And because existing medicine a multitude of names, general patient is difficult to select the medicine treatment according to self disease oneself.
In addition, it is Western medicine greatly that existing medicine has, and not only expensive makes general ordinary people be difficult to bear, and has toxic and side effects usually, and patient is long-term or take in a large number and can cause the human body viscera damage and develop immunity to drugs, thoroughly radical curing of disease.Some people also can produce the phenomenon of vomiting when taking Western medicine, thereby has increased patient's misery.
In this case, people turn to the traditional Chinese medical science to the hope of treatment.Yet, the medicine that still unmatchful multiple disease can be treated simultaneously in the traditional Chinese medical science at present.
Therefore, for avoiding the problems referred to above, the necessary fat-reducing Chinese patent medicine that provides a kind of ability to eliminate fat treatment obese fatty liver disease is to overcome said defective of the prior art.
[summary of the invention]
For addressing the above problem, the object of the present invention is to provide a kind of therapeutic effect good, side effect is little, short treating period, and can treat a kind of of multiple disease simultaneously and can eliminate the fat-reducing Chinese patent medicine that fat is treated obese fatty liver disease.
For realizing above-mentioned purpose, the technical scheme that the present invention takes is: a kind of fat-reducing Chinese patent medicine that can eliminate fat treatment obese fatty liver disease, it comprises Fructus Lycii, Ganoderma, fire ginseng, Radix Ginseng, Rhizoma Polygoni Cuspidati, and Radix Glycyrrhizae.
A kind of fat-reducing Chinese patent medicine that can eliminate fat treatment obese fatty liver disease of treatment of the present invention further is: said Fructus Lycii, and Ganoderma, the fire ginseng, Radix Ginseng, Rhizoma Polygoni Cuspidati, and the proportioning of Radix Glycyrrhizae is (parts by weight are represented): 9～11 parts of Fructus Lyciis; 10～14 parts of Ganodermas; 15～20 parts of fire ginsengs; 7～9 parts of Radix Ginsengs; 10～12 parts of Rhizoma Polygoni Cuspidati; 11～15 parts in Radix Glycyrrhizae.
A kind of fat-reducing Chinese patent medicine that can eliminate fat treatment obese fatty liver disease of the present invention further is: said Fructus Lycii, and Ganoderma, the fire ginseng, Radix Ginseng, Rhizoma Polygoni Cuspidati, and the proportioning of Radix Glycyrrhizae is (parts by weight are represented): 10 parts of Fructus Lyciis; 11 parts of Ganodermas; 17 parts of fire ginsengs; 8 parts of Radix Ginsengs; 11 parts of Rhizoma Polygoni Cuspidati; 12 parts in Radix Glycyrrhizae.
A kind of fat-reducing Chinese patent medicine that can eliminate fat treatment obese fatty liver disease of the present invention can also for: said pharmaceutical formulation can be processed tablet, capsule, electuary, oral liquid or injection.
Compared with prior art, the present invention has following beneficial effect: a kind of fat-reducing Chinese patent medicine that can eliminate fat treatment obese fatty liver disease of the present invention be that pure Chinese medicine is processed, and it is good to have a therapeutic effect, and side effect is little, plurality of advantages such as short treating period; Can eliminate fat treatment obese fatty liver disease
[specific embodiment]
Below in conjunction with embodiment the present invention is done further explanation.
Embodiment 1:
A kind of fat-reducing Chinese patent medicine that can eliminate fat treatment obese fatty liver disease of the present invention is made up of following Chinese medicine: Fructus Lycii, Ganoderma, fire ginseng, Radix Ginseng, Rhizoma Polygoni Cuspidati, and Radix Glycyrrhizae.Wherein, said Fructus Lycii, Ganoderma, the fire ginseng, Radix Ginseng, Rhizoma Polygoni Cuspidati, and the proportioning of Radix Glycyrrhizae is (parts by weight are represented): 9～11 parts of Fructus Lyciis; 10～14 parts of Ganodermas; 15～20 parts of fire ginsengs; 7～9 parts of Radix Ginsengs; 10～12 parts of Rhizoma Polygoni Cuspidati; 11～15 parts in Radix Glycyrrhizae.Said pharmaceutical formulation is processed tablet, capsule, and electuary, oral liquid or injection are to satisfy the many-sided demand of patient.
Embodiment 2:
A kind of fat-reducing Chinese patent medicine that can eliminate fat treatment obese fatty liver disease of the present invention is made up of following Chinese medicine: Fructus Lycii, Ganoderma, fire ginseng, Radix Ginseng, Rhizoma Polygoni Cuspidati, and Radix Glycyrrhizae.Wherein, said Fructus Lycii, Ganoderma, the fire ginseng, Radix Ginseng, Rhizoma Polygoni Cuspidati, and the proportioning of Radix Glycyrrhizae is (parts by weight are represented): 10 parts of Fructus Lyciis; 11 parts of Ganodermas; 17 parts of fire ginsengs; 8 parts of Radix Ginsengs; 11 parts of Rhizoma Polygoni Cuspidati; 12 parts in Radix Glycyrrhizae.Said pharmaceutical formulation is processed tablet, capsule, and electuary, oral liquid or injection are to satisfy the many-sided demand of patient.
A kind of fat-reducing Chinese patent medicine that can eliminate fat treatment obese fatty liver disease of the present invention be that pure Chinese medicine is processed, and it is good to have a therapeutic effect, and side effect is little, plurality of advantages such as short treating period; Can eliminate fat treatment obese fatty liver disease.
Claims (4)
1. the fat-reducing Chinese patent medicine that can eliminate fat treatment obese fatty liver disease is characterized in that: comprise Fructus Lycii, Ganoderma, fire ginseng, Radix Ginseng, Rhizoma Polygoni Cuspidati, and Radix Glycyrrhizae.
2. a kind of fat-reducing Chinese patent medicine that can eliminate fat treatment obese fatty liver disease as claimed in claim 1 is characterized in that: said Fructus Lycii, and Ganoderma, the fire ginseng, Radix Ginseng, Rhizoma Polygoni Cuspidati, and the proportioning of Radix Glycyrrhizae is (parts by weight are represented):
9～11 parts of Fructus Lyciis;
10～14 parts of Ganodermas;
15～20 parts of fire ginsengs;
7～9 parts of Radix Ginsengs;
10～12 parts of Rhizoma Polygoni Cuspidati;
11～15 parts in Radix Glycyrrhizae.
3. a kind of fat-reducing Chinese patent medicine that can eliminate fat treatment obese fatty liver disease as claimed in claim 2 is characterized in that: said Fructus Lycii, and Ganoderma, the fire ginseng, Radix Ginseng, Rhizoma Polygoni Cuspidati, and the proportioning of Radix Glycyrrhizae is (parts by weight are represented): 10 parts of Fructus Lyciis; 11 parts of Ganodermas; 17 parts of fire ginsengs; 8 parts of Radix Ginsengs; 11 parts of Rhizoma Polygoni Cuspidati; 12 parts in Radix Glycyrrhizae.
4. a kind of fat-reducing Chinese patent medicine that can eliminate fat treatment obese fatty liver disease as claimed in claim 3, it is characterized in that: said pharmaceutical formulation can be processed tablet, capsule, electuary, oral liquid or injection.Eliminate fat treatment obese fatty liver disease.The high characteristics of instant effect cure rate are arranged.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104330257A CN102430007A (en) | 2011-12-22 | 2011-12-22 | Weight-losing Chinese patent medicine capable of eliminating fat and treating fatty liver obesity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104330257A CN102430007A (en) | 2011-12-22 | 2011-12-22 | Weight-losing Chinese patent medicine capable of eliminating fat and treating fatty liver obesity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102430007A true CN102430007A (en) | 2012-05-02 |
Family
ID=45978592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104330257A Pending CN102430007A (en) | 2011-12-22 | 2011-12-22 | Weight-losing Chinese patent medicine capable of eliminating fat and treating fatty liver obesity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102430007A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103055129A (en) * | 2013-02-08 | 2013-04-24 | 黄晶晶 | Traditional Chinese medical preparation for treating hyperlipidemia |
-
2011
- 2011-12-22 CN CN2011104330257A patent/CN102430007A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103055129A (en) * | 2013-02-08 | 2013-04-24 | 黄晶晶 | Traditional Chinese medical preparation for treating hyperlipidemia |
| CN103055129B (en) * | 2013-02-08 | 2013-12-18 | 黄晶晶 | Traditional Chinese medicine preparation for treating hyperlipidemia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102697868A (en) | Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis | |
| CN102697898A (en) | Medicament for regulating endocrine and curing dysmenorrheal, mammary gland hyperplasia and breast dysplasia | |
| CN101856426A (en) | Medicament for treating rheumatic arthritis and preparation method thereof | |
| CN102430007A (en) | Weight-losing Chinese patent medicine capable of eliminating fat and treating fatty liver obesity | |
| CN102327493A (en) | Medicine for treating tracheitis, rhinitis, pharyngitis, pneumonectasis, pulmonary heart diseases and asthmatic diseases | |
| CN102988712A (en) | Traditional Chinese medicine for treating cough and preparation method of traditional Chinese medicine | |
| CN102343038A (en) | Medicament for treating cerebrosis such as hemiplegic cerebral palsy, falling sickness, Parkinson, headache, insomnia and the like | |
| CN102423359A (en) | Drug for restoring renal functions and curing various nephrosis such as nephritis, uremia and the like | |
| CN103656179B (en) | A kind of Chinese medicine composition for the treatment of phlegm dyspnea | |
| CN102670817A (en) | Medicament for treating various blood diseases such as thrombocytopenia, purpura and leukaemia | |
| CN104547927A (en) | Medicine for treating child anorexia and preparation method of medicine | |
| CN102327492A (en) | Medicine for treating amyotrophia and myasthenia, myodystrophy and motor neuron injury | |
| CN103877193A (en) | Medicine for treating hepatopathy | |
| CN102343039A (en) | Drug for treating skin diseases such as psoriasis, leucoderma, ichthyosis, eczema and the like | |
| CN102343042A (en) | Medicine for treating cardiovascular diseases of hypertension, cardiopathy and cerebral thrombus | |
| CN102697869A (en) | Medicine capable of regulating blood surger level, restoring pancreatic function and curing diabetes mellitus | |
| CN102343037A (en) | Drug with effects of bacterium resistance, disinfection, blood circulation promotion, blood stasis removal, immunity improvement, life prolonging and aging delay | |
| CN102343040A (en) | Drug for treating otitis media, deaf and tinnitus | |
| CN105213706A (en) | One is used for the treatment of osteoporotic two celestial kidney qi soup | |
| CN105267832A (en) | Ginseng, poria cocos and rhizoma atractylodis macrocephalae powder modified formula for treating osteoporosis | |
| CN102247543A (en) | Hepatitis B virus killing medicine for treating hepatitis B with positive HBsAg, HBeAg and HBcAb, hepatitis B with positive HBsAg, HBeAb and HBcAb and various liver diseases | |
| CN105311310A (en) | Kidney-tonifying and essence-replenishing decoction for treating osteoporosis | |
| CN104338004A (en) | Qi-regulating composing powder | |
| CN102920798A (en) | Medicinal composition for treating pig influenza | |
| CN104043074A (en) | Traditional Chinese medicine preparation for treating enduring cough for many years |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C05 | Deemed withdrawal (patent law before 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120502 |